Groups | Inoculum dose (PFU/mL) | Mortality | Fecal shedding, log10 copies/mL, by PID, mean | Onset of clinical signs as judged by PIHa | Quantification of Viral load, log10 copies/mL, mean | PEDV antigen detection in frozen tissuesb | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 3 | 5 | 7 | 9 | 11 | 14 | D | J | I | D | J | I | ||||
17GXCZ-1ORF3d-P15 (Group A) | 1.0 × 106 (2 mL) | 100%, 4/4 | 7.12 | 8.37 | / | / | / | / | / | 14–36 | 5.79 | 7.62 | 7.54 |  +  |  +  +  +  |  +  +  +  |
17GXCZ-1ORF3d-P90 (Group B) | 1.0 × 106 (2 mL) | 25%, 1/4 | - | 0.99 | 3.42 | – | – | – | – | 120–144 | 1.13 | 2.08 | 1.15 | – | – | – |
17GXCZ-1ORF3d-P120 (Group C) | 1.0 × 106 (2 mL) | 0%, 0/4 | - | 0.99 | 1.36 | 1.16 | 1.15 | 1.43 | - | – | – | – | 1.11 | – | – | – |
17GXCZ-1ORF3c-P15 (Group D) | 1.0 × 106 (2 mL) | 100%, 4/4 | 3.31 | 6.98 | / | / | / | / | / | 18–36 | 5.62 | 3.82 | 6.27 | – |  +  +  |  +  +  +  |
17GXCZ-1ORF3c-P90 (Group E) | 1.0 × 106 (2 mL) | 100%, 4/4 | 5.20 | 5.38 | 6.15 | / | / | / | / | 30–54 | 3.38 | 3.12 | 5.42 | – |  +  +  |  +  |
17GXCZ-1ORF3c-P120 (Group F) | 1.0 × 106 (2 mL) | 50%, 2/4 | 5.19 | 6.15 | 6.86 | 4.23 | 6.28 | 5.46 | 4.04 | 24–120 | 1.17 | 2.04 | 2.68 | – | – |  +  +  +  |
Mock (Group G) | GM (2 mL) | 0%, 0/4 | – | – | – | – | – | – | – | – | – | – | – | – | – | – |